Insiders Trades

★ Sign in to follow

PC

Paul Crossett

NexgenRx Inc.

Cumul. flow

Total declarations

306

Company

1

▲ Purchases (299 ops.)

€10.2M

▼ Sales (0 ops.)

—

Latest filing published 01 Oct 2024 for NexgenRx Inc., €2,331.

Filing timeline

BuySale

Paul Crossett

First 200 filings with a declared amount

Insider track record

Disclosed buys

299

Disclosed sells

0

Signal history

Paul Crossett: trading record in brief

Paul Crossett discloses dealings in NexgenRx Inc. to SEDI. Between 9 November 2015 and 1 October 2024, the trades on record add up to 306 filings.

No open-market sale appears; the market trades are 299 purchases worth €10.2M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2024 to date brings 10 purchases and no sales.

A typical purchase (the median) is worth €2,492. The 268 purchases reviewed show no overlap with other insiders buying the same stock within a month.

Most recently, on 1 October 2024, the filings show an open-market purchase worth €2,331 in NexgenRx Inc. Publication is fast: at least half of the trades appear on SEDI on the same day. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Paul Crossett

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

NexgenRx Inc. (CA)

Declarations304 total

▲

3 - 10% Security Holder of IssuerExecutives1 Oct 2024NexgenRx Inc.

3,480 CAD0SEDI

14,500 shares@ CA$0.24Common SharesTSXSEDI:4381930

Canonical exit: 30 Dec 2024 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives17 Sept 2024NexgenRx Inc.

5,000 CAD11SEDI

20,000 shares@ CA$0.250.3% of flowCommon SharesTSXSEDI:4376144

Canonical exit: 16 Dec 2024 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives13 Sept 2024NexgenRx Inc.

3,750 CAD11SEDI

15,000 shares@ CA$0.250.2% of flowCommon SharesTSXSEDI:4374868

Canonical exit: 12 Dec 2024 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives22 Aug 2024NexgenRx Inc.

120 CAD0SEDI

500 shares@ CA$0.24Common SharesTSXSEDI:4365451

Canonical exit: 20 Nov 2024 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives14 Aug 2024NexgenRx Inc.

5,000 CAD11SEDI

20,000 shares@ CA$0.250.3% of flowCommon SharesTSXSEDI:4361889

Canonical exit: 12 Nov 2024 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives7 Aug 2024NexgenRx Inc.

1,300 CAD11SEDI

5,000 shares@ CA$0.260.1% of flowCommon SharesTSXSEDI:4360294

Canonical exit: 5 Nov 2024 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives7 Aug 2024NexgenRx Inc.

2,600 CAD11SEDI

10,000 shares@ CA$0.260.2% of flowCommon SharesTSXSEDI:4358580

Canonical exit: 5 Nov 2024 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives2 Aug 2024NexgenRx Inc.

3,510 CAD0SEDI

13,500 shares@ CA$0.26Common SharesTSXSEDI:4355121

Canonical exit: 31 Oct 2024 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives2 Aug 2024NexgenRx Inc.

2,700 CAD0SEDI

10,000 shares@ CA$0.27Common SharesTSXSEDI:4355116

Canonical exit: 31 Oct 2024 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives23 May 2024NexgenRx Inc.

13,860 CAD5SEDI

49,500 shares@ CA$0.281.0% of flowCommon SharesTSXSEDI:4318447

Canonical exit: 21 Aug 2024 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives11 Sept 2023NexgenRx Inc.

3,780 CAD9SEDI

14,000 shares@ CA$0.270.2% of flowCommon SharesTSXSEDI:4181975

Canonical exit: 10 Dec 2023 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives7 Sept 2023NexgenRx Inc.

2,970 CAD0SEDI

11,000 shares@ CA$0.27Common SharesTSXSEDI:4180478

Canonical exit: 6 Dec 2023 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives7 Sept 2023NexgenRx Inc.

2,700 CAD0SEDI

10,000 shares@ CA$0.27Common SharesTSXSEDI:4180474

Canonical exit: 6 Dec 2023 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives8 Dec 2021NexgenRx Inc.

1,080 CAD11SEDI

3,000 shares@ CA$0.360.4% of flowCommon SharesTSXSEDI:3844441

Canonical exit: 8 Mar 2022 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives8 Dec 2021NexgenRx Inc.

1,110 CAD11SEDI

3,000 shares@ CA$0.370.4% of flowCommon SharesTSXSEDI:3844442

Canonical exit: 8 Mar 2022 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives3 Dec 2021NexgenRx Inc.

4,070 CAD9SEDI

11,000 shares@ CA$0.371.4% of flowCommon SharesTSXSEDI:3842121

Canonical exit: 3 Mar 2022 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives22 Nov 2021NexgenRx Inc.

9,000 CAD7SEDI

25,000 shares@ CA$0.363.2% of flowCommon SharesTSXSEDI:3835551

Canonical exit: 20 Feb 2022 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives22 Sept 2021NexgenRx Inc.

5,040 CAD5SEDI

14,000 shares@ CA$0.361.7% of flowCommon SharesTSXSEDI:3806792

Canonical exit: 21 Dec 2021 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives15 Sept 2021NexgenRx Inc.

6,383 CAD11SEDI

18,500 shares@ CA$0.3450.5% of flowCommon SharesTSXSEDI:3804038

Canonical exit: 14 Dec 2021 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives13 Sept 2021NexgenRx Inc.

690 CAD11SEDI

2,000 shares@ CA$0.3450.1% of flowCommon SharesTSXSEDI:3802825

Canonical exit: 12 Dec 2021 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives8 Sept 2021NexgenRx Inc.

345 CAD11SEDI

1,000 shares@ CA$0.3450.0% of flowCommon SharesTSXSEDI:3800648

Canonical exit: 7 Dec 2021 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives8 Sept 2021NexgenRx Inc.

3,500 CAD11SEDI

10,000 shares@ CA$0.350.3% of flowCommon SharesTSXSEDI:3800647

Canonical exit: 7 Dec 2021 (T+90)

●

3 - 10% Security Holder of IssuerExecutives7 Sept 2021NexgenRx Inc.

1,775 CAD11SEDI

5,000 shares@ CA$0.3550.1% of flowCommon SharesTSXSEDI:3799929

▲

3 - 10% Security Holder of IssuerExecutives3 Sept 2021NexgenRx Inc.

1,775 CAD11SEDI

5,000 shares@ CA$0.3550.1% of flowCommon SharesTSXSEDI:3798393

Canonical exit: 2 Dec 2021 (T+90)

▲

3 - 10% Security Holder of IssuerExecutives2 Sept 2021NexgenRx Inc.

355 CAD11SEDI

1,000 shares@ CA$0.3550.0% of flowCommon SharesTSXSEDI:3797417

Canonical exit: 1 Dec 2021 (T+90)

25 of 304 declarations